BioSpace News Archive

Forbius, a clinical-stage company developing biologics for the treatment of cancer and fibrosis, announced today that the Food and Drug Administration (FDA)) has approved its investigational new drug (IND) application to conduct a Phase 1 clinical trial in solid tumors with immuno-oncology candidate AVID200, a rationally designed inhibitor of TGF-beta 1 & 3.

Making the Most of the Bonding Opportunities the Holidays Bring

Today, LGC announced the acquisition of SeraCare Life Sciences, Inc., a manufacturer and leading partner to global in vitro diagnostics manufacturers and clinical laboratories.

Infervision, a tech company using big data and artificial intelligence (AI) to assist and improve medical diagnoses, announced the launch of InferRead CT Chest, a new product concept that detects four different conditions with just one set of chest scans, leading to faster and more comprehensive medical diagnoses.

ScriptSender has implemented a suite of technology solutions at Northeast Radiology (NERAD), enabling the radiology provider to streamline operations and communicate much more effectively with its referrers.

Technavio analysts forecast the global anthrax treatment market to grow at a CAGR of over 8% during the forecast period, according to their latest market research report.

Today, surrounded by industry leaders, researchers and students, the National Research Council of Canada (NRC) and the University of Toronto (U of T) celebrated the opening of the Centre for Research and Application in Fluidic Technologies (CRAFT).

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has approved ACTPen™ 162 mg/0.9 mL, a single-dose prefilled autoinjector for Actemra®

Breakthrough Strategy (BTS), working on behalf of the International Society on Thrombosis and Haemostasis (ISTH), will lead an international project to develop venous thromboembolism (VTE) clinical research standards beginning in December 2018.

Sunrise Senior Living is enhancing residents’ wellbeing at U.S. communities through individualized programming that includes the use of award-winning therapeutic music technology, SingFit™